Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Merck Kgaa (MRK.D.DX)

Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merck Kgaa Frankfurter Strasse 250 Darmstadt HE 64293 DEU

P: +49 6151720

Description:

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Key Statistics

Overview:

Market Capitalization, $K 71,607,917
Shares Outstanding, K 434,778
Annual Sales, $ 20,993 M
Annual Net Income, $ 2,824 M
Last Quarter Sales, $ 5,352 M
Last Quarter Net Income, $ 607,000 K
% of Institutional Shareholders 15.84%

Growth:

1-Year Return 7.57%
3-Year Return -23.57%
5-Year Return 0.00%
5-Year Revenue Growth 7.19%
5-Year Earnings Growth -3.51%
5-Year Dividend Growth 11.97%

Per-Share Information:

Most Recent Earnings 1.40 on 07/30/24
Next Earnings Date N/A
Earnings Per Share ttm 6.03
EPS Growth vs. Prev Qtr -12.50%
EPS Growth vs. Prev Year -14.69%
Annual Dividend Rate, $ 2.20
Annual Dividend Yield 1.41%
Most Recent Dividend 2.200 on 04/29/24
Next Ex-Dividends Date 04/29/24
Dividend Payable Date 05/02/24
Dividend Payout Ratio 36.48%
Most Recent Split 2-1 on 06/30/14

MRK.D.DX Ratios

Ratio
Price/Earnings ttm 25.79
Price/Earnings forward 15.65
Price/Earnings to Growth 2.37
Return-on-Equity % 9.51%
Return-on-Assets % 5.32%
Profit Margin % 13.45%
Debt/Equity 0.35
Price/Sales 3.24
Price/Cash Flow 16.08
Price/Book 2.37
Book Value/Share 65.66
Interest Coverage 11.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar